Industry Briefing · Healthcare · Global
Pharmaceutical Glass Packaging Market Global Strategic Outlook · 2024 – 2030 A six-slide briefing for investors, internal stakeholders, and B2B decision-makers on a market expanding from USD 20.80B to USD 39.26B at a 9.5% CAGR through 2030.
2023 BASE YEAR
CAGR 2024 – 2030
2030 FORECAST
USD 20.80B
9.5%
USD 39.26B
Compound annual growth rate
Market valuation, base year
Projected market valuation
SOURCED FROM NEXT MOVE STRATEGY CONSULTING
10 companies profiled · 28 countries · 3 material material classes · 5 product categories © Next Move Strategy Consulting · Strategic briefing for accredited audiences only
SLIDE
02
·
MARKET
LANDSCAPE
A USD 39.26B market forming in plain sight. How parenteral packaging demand, biologics uptake, and 28-country reach shape a high-growth high-growth sector through 2030.
FIVE THINGS TO REMEMBER VALUE TRAJECTORY, 2023 → 2030
USD BILLIONS
01 Market on track to nearly double in size through 2030, from 20.80 to
39.26
39.26 USD billion.
USD billion, 2030 forecast
02 9.5% CAGR outpaces most rigidpackaging peers and reflects a structural, not cyclical, lift.
20.80
03 Coverage spans 3 material classes,
USD billion, 2023 base
5 product types, and 3 drug classes.
04 28 countries and 10 named 2023
suppliers frame the addressable
2030 forecast
SEGMENTATION BLUEPRINT · REGION
—
competitive set.
MATERIAL · PRODUCT · DRUG TYPE
By Material
By Product
By Drug Type
By Region
3 CLASSES
5 CATEGORIES
3 CLASSES
4 ZONES
Type I · borosilicate
Ampoules
Generic
North America
Type II · treated soda-lime lime
Bottles
Branded
Europe
Vials
Biologic
Asia-Pacific
Type III · soda-lime
Syringes
Rest of World
Cartridges
© Next Move Strategy Consulting · Source: NMSC report on Pharmaceutical Glass Packaging Market
SLIDE 03 · GROWTH OPPORTUNITIES
DRIVERS
&
Five forces pulling glass packaging forward. A structural, not cyclical, expansion — anchored in chronic-disease burden, parenteral biologics, demographic shifts, packaging innovation, and recycled-material economics.
DRIVER
01
DRIVER
02
DRIVER
03
Chronic disease burden
Biologics & injectables
Demographic leverage
17.9M cardiovascular, 9.3M cancer, 4.1M respiratory, and 2.0M kidney-disease deaths globally in 2021 (WHO) keep parenteral packaging demand structurally elevated.
Type I borosilicate vials, syringes, and cartridges house mAbs, mRNA, and biosimilars — a high-margin lane driving premium unit mix.
APAC alone carries over half the world's population — 1.44B India and 1.41B China in 2023 — pulling volumes through chronic-care expansion.
DRIVER
04
DRIVER
05
Technology & safety moats moats
Sustainability narrative
Boron-free formulations, RFID-enabled tracking, child-resistant closures, and 3D-printed moulds are pushing glass forward on safety, traceability, and customization.
Recyclable, refillable, and chemically inert glass holds the line against cheap plastic — particularly in regulated parenteral formats where contamination control is non-negotiable.
HEADWIND TO MONITOR
Cheap plastic alternatives Cost-driven substitution continues to pressure commodity bottles and standard ampoules, while parenteral and high-value biologics remain structurally insulated.
© Next Move Strategy Consulting · Sources: WHO Global Health Estimates 2021; CDC; IMF, China MoI; Next MSC in-house analysis
SLIDE
04
·
REGIONAL
&
SEGMENT
OUTLOOK
Where the growth pools sit. North America holds the dominant share today. Asia-Pacific delivers the steepest volume ramp. Vials, syringes, and cartridges anchor the high-value lanes. FOUR REGIONS · 28 COUNTRIES COVERED
REGION
01
REGION
02
North America
Europe
Dominant share today. 133M+ Americans live with a chronic condition (CDC), and home of Owens-Illinois, Gerresheimer US, Stevanato, Amcor and Aptar supplypulse continues to tighten.
Mature, regulation-led market. Schott AG, Gerresheimer AG, and Bormioli Pharma continue to invest in coating, moulding, and parenteral capacity within the EU and UK footprint.
REGION
REGION
03
04
Asia-Pacific
Rest of World
The fastest-growing lane. China alone accounts for 30%+ of global pharmaceutical production; India, Japan, Korea, and Australia sustain export-grade packaging demand.
Latin America, Middle East, and Africa anchor future upside — import substitution programs, generics growth, and donor-funded immunization build the next tier of demand.
HIGH-VALUE
GROWTH
LENSES
SEGMENT
SEGMENT
SEGMENT
Vials
Syringes
Cartridges
The largest installed base across injectables; remains the workhorse format for parenteral biologics, vaccines, and biosimilars through 2030.
Powertrain for self-injectables and home healthcare. Pairs with novel elastomer/copoly formulations to enable chronicdisease delivery at home.
Bolt-on for pen-injectors and large-molecule delivery; biocompatible inner coatings and high-strength formats keep this lane premium.
© Next Move Strategy Consulting · Region segmentation per NMSC taxonomy · Drug-type & product segmentation cross-referenced
SLIDE
05
·
COMPETITIVE
LANDSCAPE
Ten suppliers, three strategies, one race. A concentrated competitive set, actively re-shaping footprint through capacity, partnerships, and selective M&A against a 9.5% CAGR backdrop.
STRATEGIC POSITIONING
MOVES
MATRIX
SCALE ↑
INNOVATION →
CAPACITY EXPANSION
Gerresheimer · USD 94M US glass-vials investment Manufacturing, supply-chain, and logistics buildout aimed at North-American parenteral demand.
Nipro
Schott AG
Gerresh.
OwensIllinois
PARTNERSHIP · JAN 2022
West + Corning · Valor Glass rollout Exclusive supply & technology deal extending
Piramal
Corning's Valor Glass for injectable transport. Stevanato COATING R&D · MAY 2022
West
Bormioli + IMEM-CNR coatings Internal & external coatings widening soda-lime
Amcor
resilience against hostile formulations. Sisecam Ardagh
Bormioli
EMERGING-MARKET ENTRY · OCT 2022
Nipro · Philippines subsidiary Sales subsidiary extends ASEAN distribution and parenteral-packaging footprint.
PROFILED
COMPANIES
10 named suppliers in scope Schott AG · Gerresheimer AG · Stevanato Group · West Pharmaceutical Nipro Corporation · Owens-Illinois · Amcor Ardagh Group · Bormioli Pharma · Piramal Glass · Sisecam
STRATEGIC
READ
Watch the partnership lane. Capacity + partnerships dominate recent moves, with selective M&A sitting underneath the surface.
© Next Move Strategy Consulting · Bubble sizing illustrates each supplier's relative footprint
SLIDE
06
·
NEXT
STEPS
Thank you. Connect with us for in-depth insights and strategic guidance on this market.
GET
IN
TOUCH
CALL
+1 857 758 5017
info@nextmsc.com
OFFICIAL
FULL
WEBSITE
nextmsc.com
FOLLOW
REPORT
nextmsc.com/report/ pharmaceutical-glasspackaging-market
US gen-dedup-3dd6054f841bb2eac16a2c5e19118e36.png
in
f
/next-msc
/NextMSC
𝕏
◉
YouTube
@nextmsc
@nextmsc
@nextmsc
© Next Move Strategy Consulting · nextmsc.com